ArticleMedicine2025
Lateral lymph node dissection combined with endoscopic submucosal dissection for early rectal cancer complicated with ulcerative colitis: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of Influencing Factors and Establishment of Nomogram Model for Textbook Outcome Achievement in Laparoscopic Resection of Hepatocellular Carcinoma.Journal of hepatocellular carcinoma · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleEarly rectal cancer is mostly confined to the mucosa or submucosa, and metastasis to lymph nodes is rare. Stage 0 rectal cancer can usually be cured by endoscopic resection. However, when patients present with enlarged lateral lymph nodes of uncertain nature, additional surgical intervention should be considered. This article reports a case of early rectal cancer combined with ulcerative colitis. Preoperative imaging examination revealed enlarged right-sided group 263D lymph nodes. Since the nature of the enlarged lymph nodes cannot be determined, it was decided to perform lateral lymph node dissection combined with endoscopic submucosal dissection to achieve clear diagnosis and treatment. This article aims to illustrate the importance of individualized treatment for patients with early rectal cancer with complex clinical backgrounds and the clinical value of lateral lymph node dissection combined with endoscopic submucosal dissection. PATIENT CONCERNS: The patient was a 66-year-old male who presented with blood in the stool for 1 month with no family history of hereditary tumors. DIAGNOSIS: Colonoscopy and further biopsy diagnosed early rectal malignancy (stage 0). Pelvic magnetic resonance and enhanced computed tomography showed enlarged right group 263D lymph nodes with well-defined borders, approximately 1.2 cm in diameter. Together with the patient's history, the possibility of metastasis of rectal cancer was considered, but the lymph nodes were diagnosed as reactive hyperplasia after lateral lymph node dissection.
interventionsSince the nature of the enlarged lymph nodes could not be determined, it was decided to first perform lateral lymph node dissection to rule out the possibility of metastasis, followed by endoscopic submucosal dissection to remove the tumor. OUTCOMES: The patient recovered well after surgery. Pathological examination showed reactive hyperplasia of the lymph nodes, and the tumor was completely resected with negative margins. LESSONS: Lymph node metastases rarely occur in early rectal cancer, but this possibility should not be ignored, especially when dealing with patients with complex clinical backgrounds. This case also emphasizes the importance of individualized diagnosis as well as the extremely high clinical value of Lateral lymph node dissection combined with endoscopic submucosal dissection, and provides a reference for the diagnosis and treatment of similar cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.